je.st
news
AbbVie Cites Tax Break as a Shire Deal Motivator
2014-06-25 20:09:53| Biotech - Topix.net
U.S. drugmaker AbbVie sees a compelling tax break behind its roughly $46 billion bid to buy British counterpart Shire, and it expects the deal to expand Shire's global reach as well.
Tags: break
tax
deal
cites
Category:Biotechnology and Pharmaceuticals